LucyTx-1209

N/A

Report date: 2022/12/19 14:47:30
NME

Base Information

Drug NameLucyTx-1209
Drug Alias NameLucyTx-1209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP synthase inhibitors
TargetsATP synthase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLucy Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLucy Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A